Related Experiment Video
Updated: Jul 31, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
The prevalence and risk factors of anxiety in multiple sclerosis: A systematic review and meta-analysis
Xiaoyun Zhang1,2, Ying Song1, Zhiqiang Wei1
1Neurology Department, Peking University Shenzhen Hospital, Shenzhen, China.
Background:
Patients with multiple sclerosis (MS) suffer from repetitive neurological deterioration, while anxiety may play a significant role in the disease's progression.
Objective:
To explore the prevalence of anxiety in MS and to investigate the risk factors related to anxiety in MS patients.
Methods:
An analysis of four databases, PubMed, Web of Science, EMBASE, and Cochrane Library, has been conducted to determine the prevalence or risk factors for anxiety in MS published before May 2021.
Results:
In total, 32 studies were found to be eligible. Anxiety prevalence was estimated to be 36% based on the pooled estimates [the 95% confidence interval (CI) = [0.30-0.42], I 2 = 98.4%]. Significant risk factors for developing of anxiety were as follows: age at survey [the weighted mean difference (WMD) = 0.96, 95% CI = [0.86-1.06], I 2 = 43.8%], female [the odd ratio (OR) = 1.78, 95% CI = [1.38-2.30], I 2 = 0%], living together (OR 2.83, 95% CI = [1.74-4.59], I 2 = 0%), past psychiatric history (OR 2.42, 95% CI = [1.56-3.75], I 2 = 0%), depression (OR 7.89, 95% CI = [3.71-16.81], I 2 = 0%), not taking MS medication (OR 2.33, 95% CI = [1.29-4.21], I 2 = 77.8%), relapsing-remitting MS (RRMS) (OR 1.50, 95% CI = [0.94-2.37], I 2 = 53.5%), and baseline Expanded Disability Status Scale (EDSS) (OR 0.84, 95% CI = [0.48-1.21], I 2 = 62.2%).
Conclusion:
An estimated 36% of people with MS suffer from anxiety. And anxiety rates in MS patients are significantly associated with age, gender, living together, prior psychiatric history, depression, drug compliance, RRMS, and baseline EDSS.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=287069, identifier CRD42021287069.
Insights
Anxiety affects 36% of multiple sclerosis (MS) patients, with risk factors including age, female gender, living situation, psychiatric history, depression, and disease characteristics. Understanding these factors is crucial for managing MS progression.
Area of Science:
- Neurology
- Psychiatry
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease characterized by progressive deterioration.
- Anxiety is increasingly recognized as a significant factor influencing the progression of MS.
- Understanding the prevalence and risk factors of anxiety in MS is critical for patient care.
Conclusions:
- Anxiety is prevalent in 36% of individuals with MS.
- Key factors associated with anxiety in MS include demographic, psychiatric, and disease-specific variables.
- These findings highlight the need for integrated care approaches addressing both neurological and psychological well-being in MS management.
Related Concept Videos
Generalized Anxiety Disorder
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Panic Disorder
Social Anxiety Disorder
Psychoneuroimmunology: Diabetes and Cancer

